Page last updated: 2024-08-24

irinotecan and i(3)so3-galactosylceramide

irinotecan has been researched along with i(3)so3-galactosylceramide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Colman, H; Conrad, CA; Emmett, MR; He, H; Ji, Y; Kroes, RA; Lang, FF; Marshall, AG; Moskal, JR; Nilsson, CL	1

Other Studies

1 other study(ies) available for irinotecan and i(3)so3-galactosylceramide

Article	Year
Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, irinotecan. Glycoconjugate journal, 2010, Volume: 27, Issue:1 Topics: Animals; Camptothecin; Cell Line, Tumor; Gangliosides; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Glioma; Glycomics; Humans; Irinotecan; Lipids; Mice; Phosphatidylglycerols; Sulfoglycosphingolipids; Topoisomerase I Inhibitors; Tumor Suppressor Protein p53	2010

Article

Year

Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, irinotecan.

Glycoconjugate journal, 2010, Volume: 27, Issue:1

Topics: Animals; Camptothecin; Cell Line, Tumor; Gangliosides; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Glioma; Glycomics; Humans; Irinotecan; Lipids; Mice; Phosphatidylglycerols; Sulfoglycosphingolipids; Topoisomerase I Inhibitors; Tumor Suppressor Protein p53

2010